Epidemiology and risk factors of HCV infection among hemodialysis patients in countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A quantitative review of literature

Journal of Public Health

Volumn 19, Issue 2, 2011, Pages 191-203

  Alavian, Seyed Moayed ^a   Tabatabaei, Seyed Vahid ^a   Mahboobi, Nastaran ^b  

^a Baqiyatallah Medical Sciences University Baqyatallah Hospital   (Iran)

^b Tehran Hepatitis Center   (Iran)

Author keywords

EMRO; HCV; Hemodialysis; Iran; Meta analysis; Systematic review

Indexed keywords

AGE; COMORBIDITY; EGYPT; GENDER; HEMODIALYSIS PATIENT; HEPATITIS C; HUMAN; IRAN; MOROCCO; REVIEW; RISK FACTOR; SAUDI ARABIA; SYSTEMATIC REVIEW; TUNISIA; WORLD HEALTH ORGANIZATION;

EID: 79958012583     PISSN: 09431853     EISSN: 16132238     Source Type: Journal    
DOI: 10.1007/s10389-010-0366-2     Document Type: Review

References (107)

1. Abboud O, Rashid A, Al-Kaabi S (1995) Hepatitis C virus infection in hemodialysis patients in Qatar. Saudi J Kidney Dis Transplant 6:151-153
2. Abdel-Wahab MF, Zakaria S, Kamel M et al (1994) High seroprevalence of hepatitis C infection among risk groups in Egypt. Am J Trop Med Hyg 51:563-567 (Pubitemid 24378550)
3. Abdel Hady SI, El-Din MS, El-Din ME (1998) A high hepatitis E virus (HEV) seroprevalence among unpaid blood donors and haemodialysis patients in Egypt. J Egypt Public Health Assoc 73:165-179
4. Abdelnour GE, Matar GM, Sharara HM, Abdelnoor AM (1997) Detection of anti-hepatitis C-virus antibodies and hepatitis C-virus RNA in Lebanese hemodialysis patients. Eur J Epidemiol 13:863-867 (Pubitemid 28046713)
5. Abdulkarim AS, Zein NN, Germer JJ et al (1998) Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis C virus subtypes. Am J Trop Med Hyg 59:571-576 (Pubitemid 28480713)
6. Agarwal SK, Dash SC et al (1999) Hepatitis C virus infection during haemodialysis in India. J Assoc Physicians India 47:1139-1143
7. al-Dhahry SH, Aghanashinikar PN, Al-Hasani MK, Buhl MR, Daar AS (1992) Antibodies to hepatitis C virus in Omani patients with renal disease. Transplant Proc 24:1938-1939
8. al-Dhahry SH, Aghanashinikar PN, Al-Hasani MK, Buhl MR, Daar AS (1993) Prevalence of antibodies to hepatitis C virus among Omani patients with renal disease. Infection 21:164-167 (Pubitemid 23197144)
9. Al-Jiffri AM, Fadag RB, Ghabrah TM, Ibrahim A (2003) Hepatitis C virus infection among patients on hemodialysis in Jeddah: a single center experience. Saudi J Kidney Dis Transplant 14:84-89 (Pubitemid 36289804)
10. Al-Muhanna FA (1995) Hepatitis C virus infection among hemodialysis patients in the eastern region of Saudi Arabia. Saudi J Kidney Dis Transplant 6:125-127
11. Al Meshari K, Al Ahdal M, Alfurayh O, Ali A, De Vol E, Kessie G (1995) New insights into hepatitis C virus infection of hemodialysis patients: the implications. Am J Kidney Dis 25:572-578
12. Al Shohaib SS, Abdelaal MA, Zawawi TH, Abbas FM, Shaheen FA, Amoah E (1995) The prevalence of hepatitis C virus antibodies among hemodialysis patients in the Jeddah area, Saudi Arabia. Saudi J Kidney Dis Transplant 6:128-131
13. Alavian SM (2006) Hepatitis C, chronic renal failure, control is possible! Hepat Mon 6:51-552
14. Alavian SM (2009) A shield against a monster: hepatitis C in hemodialysis patients. World J Gastroenterol 15:641-646
15. Alavian SM, Einollahi B, Hajarizadeh B, Bakhtiari S, Nafar M, Ahrabi S (2003) Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients. Nephrology (Carlton) 8:256-260 (Pubitemid 37430951)
16. Alavian SM, Kafaee J, Yektaparast B, Rad N, Bakhtiari S, Hajarizadeh B, Sadri M (2004) Prevalence and risk factors for acquiring hepatitis C in hemodialysis patients in Gazvin (2001) (in Persian). J Qazvin Univ Med Sci 29:16-20
17. Alavian SM, Adibi P, Zali MR (2005) Hepatitis C virus in Iran: epidemiology of an emerging infection. Arch Iran Med 8:84-90 (Pubitemid 40613753)
18. Alavian SM, Hosseini-Moghaddam SM, Rahnavardi M (2007) Hepatitis C among hemodialysis patients: a review on epidemiologic, diagnostic, and therapeutic features. Hepat Mon 7:153-162
19. Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S (2008) Hepatitis B and C in dialysis units in Iran: changing the epidemiology. Hemodial Int 12:378-382
20. Alavian SM, Ahmadzad Asl M, Bagheri-Lankarani K, Shahbabaie MA, Bahrami Ahmadi A (2009) Hepatitis C infection in the general population of Iran: a systematic review. Hepat Mon 9:211-223
21. Albuquerque AC, Coelho MR, Lopes EP, Lemos MF, Moreira RC (2005) Prevalence and risk factors of hepatitis C virus infection in hemodialysis patients from one center in Recife, Brazil. Mem Inst Oswaldo Cruz 100:467-470 (Pubitemid 41424070)
22. Ali SA, Donahue RM, Qureshi H, Vermund SH (2009) Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis 13:9-19
23. Almawi WY, Qadi AA, Tamim H, Ameen G, Bu-Ali A, Arrayid S, Abou Jaoude MM (2004) Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia. Transplant Proc 36:1824-1826 (Pubitemid 39200437)
24. Ameen RN, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, Al-Hamdan S, Al-Bashir A (2005) Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion 45:1973-1980 (Pubitemid 43971426)
25. Amiri ZM, Shakib AJ, Toorchi M (2005) Seroprevalence of hepatitis C and risk factors in haemodialysis patients in Guilan, Islamic Republic of Iran. East Mediterr Health J 11:372-376
26. Ansar MM, Kooloobandi A (2002) Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. J Viral Hepat 9:390-392
27. Assarehzadegan MA, Shakerinejad G, Noroozkohnejad R, Amini A, Rahim Rezaee SA (2009) Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran. Saudi J Kidney Dis Transplant 20:681-684
28. Ayed K, Gorgi Y, Ben Abdallah T, Aouadi H, Jendoubi-Ayed S, Sfar I, Makni H (2003) Hepatitis C virus infection in hemodialysis patients from Tunisia: national survey by serologic and molecular methods. Transplant Proc 35:2573-2575 (Pubitemid 37378068)
29. Barril G (2000) Hepatitis C virus-induced liver disease in dialysis patients. Nephrol Dial Transplant 15 (Suppl 8):42-45 (Pubitemid 32149506)
30. Baril G, Traver JA (2003) Decrease in the hepatitis C virus (HCV) prevalence in hemodialysis patients in Spain: effect of time, initiating HCV prevalence studies and adoption of isolation measures. Antivir Res 60:129-134 (Pubitemid 37452457)
31. Ben Othman S, Bouzgarrou N, Achour A, Bourlet T, Pozzetto B, Trabelsi A (2004) High prevalence and incidence of hepatitis C virus infections among dialysis patients in the East-Centre part of Tunisia. Pathol Biol (Paris) 52:323-327 (Pubitemid 38916891)
32. Bernieh B, Allam M, Halepota A, Mohamed AO, Parkar J, Tabbakh A (1995) Prevalence of hepatitis C virus antibodies in hemodialysis patients in madinah Al munawarah. Saudi J Kidney Dis Transplant 6:132-135
33. Borenstein M, Hedges LV, Higgins J P T, Rothstein H (2009) Introduction to meta-analysis. Wiley, New York
34. Boulaajaj K, Elomari Y, Elmaliki B, Madkouri B, Zaid D, Benchemsi N (2005) Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd University Hospital, Casablanca. Néphrol Thér 1:274-284 (Pubitemid 41719286)
35. Bozorghi SH, Ramezany H, Vahid T (2006) Assessment of prevalence and risk factors of hepatitis C virus infection in haemodialysis patients in Ghazvin (In Persian). Sci J IBTO 2:331-337
36. Broumand B, Abdollah-Shamshirsaz AR, Kamgar M (2002) Prevalence of hepatitis C infection and its risk factors in hemodialysis patients in Tehran: preliminary report from "the effect of dialysis unit isolation on the incidence of hepatitis C in dialysis patients" project. Saudi J Kidney Dis Transplant 13:467-472 (Pubitemid 36111065)
37. Carneiro MA, Teles SA, Dias MA (2005) Decline of hepatitis C infection in hemodialysis patients in central Brazil: a ten years of surveillance. Mem Inst Oswaldo Cruz 100:345-349 (Pubitemid 41190685)
38. Chandra M, Khaja MN et al (2004) Prevalence of hepatitis B and hepatitis C viral infections in Indian patients with chronic renal failure. Intervirology 47:374-376 (Pubitemid 39541285)
39. Dadgaran SA (2005) Prevalence and risk factors of hepatitis C virus among hemodialysis patients. J Guilan Univ 55:76-86
40. Daw MA, Elkaber MA, Drah AM, Werfalli MM, Mihat AA, Siala IM (2002) Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk. Saudi Med J 23:1356-1360 (Pubitemid 36113491)
41. dos Santos JP, Loureiro A, Cendoroglo Neto M, Pereira BJ (1996) Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units. Nephrol Dial Transplant 11:2017-2022 (Pubitemid 26345467)
42. El-Reshaid K, Kapoor M, Sugathan T, Al-Mufti S, Al-Hilali N (1995) Hepatitis C virus infection in patients on maintenance dialysis in Kuwait: epidemiological profile and efficacy of prophylaxis. Saudi J Kidney Dis Transplant 6:144-150
43. El-Zayadi AR, Abe K, Selim O, Naito H, Hess G, Ahdy A (1999) Prevalence of GBV-C/hepatitis G virus viraemia among blood donors, health care personnel, chronic non-B non-C hepatitis, chronic hepatitis C and hemodialysis patients in Egypt. J Virol Methods 80:53-58 (Pubitemid 29248902)
44. El Shahat YI, Varma S, Bari MZ, Shah Nawaz M, Abdulrahman S, Pingle A (1995) Hepatitis C virus infection among dialysis patients in United Arab Emirates. Saudi J Kidney Dis Transplant 6:157-162
45. Elzouki AN, Bushala M, Tobji RS, Khfaifi M (1995) Prevalence of anti-hepatitis C virus antibodies and hepatitis C virus viraemia in chronic haemodialysis patients in Libya. Nephrol Dial Transplant 10:475-476
46. Espinosa M, Martn-Malo A, Ojeda R, Santamara R, Soriano S, Aguera M, Aljama P (2004) Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: causes and consequences. Am J Kidney Dis 43(4):685-689 (Pubitemid 38401883)
47. Fakunle YM, Al-Mofarreh M, El-Karamany WM, Ezzat HO, Al-Shora B, El-Drees AZ (1991) Prevalence of antibodies to hepatitis C virus in hemodialysis patients in Riyadh. Ann Saudi Med 11:504-506
48. Freitas SZ, Da Cunha RV et al (2008) Prevalence, genotypes and risk factors associated with hepatitis C virus infection in hemodialysis patients in Campo Grande, MS, Brazil. Mem Inst Oswaldo Cruz 103:405-408 (Pubitemid 352026449)
49. Gallego E, Lopez A, Perez J et al (2006) Effect of isolation measures on the incidence and prevalence of hepatitis C virus infection in hemodialysis. Nephron Clin Pract 104: C1-C6
50. Ghadir MR, Jafari E, Amiriani MT, Rezvan H, Amini S, Pourshams A (2006) Hepatitis C in Golestan Province, Iran (in Persian). Govaresh 11:158-162
51. Ghomi HA, Sammak H, Forooghi SI, Sahami M, Bitarafan M (2006) Review of hepatitis B, C and HIV in patients under hemodialysis in Qom Province in 2004. The 3rd Iranian Congress of Virology, Tehran, January 2006
52. Gohar SA, Khalil RY, Elaish NM, Khedr EM, Ahmed MS (1995) Prevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipients. J Egypt Public Health Assoc 70:465-484
53. Gul A, Iqbal F (2003) Prevalence of hepatitis C in patients on maintenance haemodialysis. J Coll Physicians Surg Pak 13:15-18 (Pubitemid 36416875)
54. Haidar NA (2002) Prevalence of hepatitis B and hepatitis C in blood donors and high risk groups in Hajjah, Yemen Republic. Saudi Med J 23:1090-1094 (Pubitemid 35331310)
55. Hassan AA, Khalil R (2000) Hepatitis C in dialysis patients in Egypt: relationship to dialysis duration, blood transfusion, and liver disease. Saudi J Kidney Dis Transplant 11:72-73
56. Higgins JP, Thompson SG, Deeks JJ, Altman DJ (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560 (Pubitemid 37088507)
57. Hmaied F, Ben Mamou M, Saune-Sandres K et al (2006) Hepatitis C virus infection among dialysis patients in Tunisia: incidence and molecular evidence for nosocomial transmission. J Med Virol 78:185-191 (Pubitemid 43132562)
58. Hussein MM, Mooij JM, Hegazy MS, Bamaga MS (2007) The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit. Saudi J Kidney Dis Transplant 18:107-113
59. Jabbari A, Besharat S, Khodabakhshi B (2008) Hepatitis C in hemodialysis centers of Golestan province, northeast of Iran (2005). Hepat Mon 8:61-65 (Pubitemid 351802699)
60. Jadoul M, Cornu C, Ypersele V, Van Ypersele de Strihou C (1998) Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group. Kidney Int 53:1022-1025 (Pubitemid 28155679)
61. Jadoul M, Poignet JL, Geddes C (2004) The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant 19:904-909 (Pubitemid 38455663)
62. Jasuja S, Gupta AK et al (2009) Prevalence and associations of hepatitis C viremia in hemodialysis patients at a tertiary care hospital. Indian J Nephrol 19:62-67
63. Jemni S, Ikbel K, Kortas M, Mahjoub J, Ghachem L, Bidet JM, Boukef K (1994) Seropositivity to hepatitis C virus in Tunisian haemodialysis patients. Nouv Rev Fr Hématol 36:349-351 (Pubitemid 24352494)
64. Johnson DW, Dent H et al (2009) Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol Dial Transplant 24:1598-1603
65. Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A (2009) Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 49:2214-2220
66. Kamel MA, Ghaffar YA, Wasef MA, Wright M, Clark LC, Miller FD (1992) High HCV prevalence in Egyptian blood donors. Lancet 340:427
67. Kashem A, Nusairat I, Mohamad M et al (2003) Hepatitis C virus among hemodialysis patients in Najran: prevalence is more among multicenter visitors. Saudi J Kidney Dis Transplant 14:206-211 (Pubitemid 36646238)
68. Khattab OS (2008) Prevalence and risk factors for hepatitis C virus infection in hemodialysis patients in an Iraqi renal transplant center. Saudi J Kidney Dis Transplant 19:110-115
69. Kheradpezhouh M, Taremi M, Gachkar L, Aghabozorgi S, Khoshbaten M (2007) Presence and significance of transfusion-transmitted virus infection in Iranian patients on maintenance hemodialysis. J Microbiol Immunol Infect 40:106-111 (Pubitemid 46999316)
70. Khokhar N, Alam AY, Naz F, Mahmud SN (2005) Risk factors for hepatitis C virus infection in patients on long-term hemodialysis. J Coll Physicians Surg Pak 15:326-328 (Pubitemid 40959790)
71. Mahdavi-Mazdeh M, Zamyadi M, Nafar M (2008) Assessment of management and treatment responses in haemodialysis patients from Tehran province, Iran. Nephrol Dial Transplant 23:288
72. Makhloogh A, Mahdavi MR, Haghshenas M, Ghasemian R, Jamshidi M (2008) Hepatitis C prevalence in hemodialysis patients in Mazandaran, Iran: a survey by polymerase chain reaction and serological methods. J Biol Sci 3:265-268
73. Mohammad-Alizadeh AH, Ranjbar M, Seifoleslami S A R (2002) The frequency of hepatitis C in dialyse patients in Hamadan Ekbatan hospital. Iran J Infect Dis Trop Med 7:27-34
74. Moukeh G, Yacoub R, Fahdi F, Rastam S, Albitar S (2009) Epidemiology of hemodialysis patients in Aleppo city. Saudi J Kidney Dis Transplant 20:140-146
75. Nemati E, Alavian SM, Taheri S, Moradi M, Pourfarziani V, Einolahi B (2009) Hepatitis C virus infection among patients on hemodialysis: a report from a single center in Iran. Saudi J Kidney Dis Transplant 20:147-153
76. Omar MN, Tashkandy MA, El Tonsy AH (1995) Liver enzymes and protein electrophoretic patterns in hemodialysis patients with antibodies against the hepatitis C virus. Saudi J Kidney Dis Transplant 6:163-166
77. Othman B, Monem F (2001) Prevalence of antibodies to hepatitis C virus among hemodialysis patients in Damascus, Syria. Infection 29:262-265 (Pubitemid 32929631)
78. Paniagua R, Villasis-Keever A et al (2010) Elevated prevalence of hepatitis B in Mexican hemodialysis patients: a multicentric survey. Arch Med Res 41:251-254
79. Petitti DB (2000) Meta-analysis, decision analysis, and costeffectiveness analysis: methods for quantitative synthesis in medicine. Oxford University Press, Oxford
80. Pol S, Romeo R, Zins B (1993) Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications. Kidney Int 44:1097-1100 (Pubitemid 23316480)
81. Qadi AA, Tamim H, Ameen G, Bu-Ali A, Al-Arrayed S, Fawaz NA, Almawi WY (2004) Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods. Am J Infect Control 32:493-495 (Pubitemid 39574475)
82. Rais-Jalali Gh, Khajehdehi P (1999) Anti-HCV seropositivity among haemodialysis patients of Iranian origin. Nephrol Dial Transplant 14:2055-2056 (Pubitemid 29358928)
83. Reddy AK, Murthy KV et al (2005) Prevalence of HCV infection in patients on haemodialysis: survey by antibody and core antigen detection. Indian J Med Microbiol 23:106-110 (Pubitemid 40712517)
84. Rezvan H, Abolghassemi H, Kafiabad SA (2007) Transfusiontransmitted infections among multitransfused patients in Iran: a review. Transfus Med 17:425-433 (Pubitemid 350198296)
85. Saab S, Brezina M, Gitnick G, Martin P, Yee HF (2001a) Hepatitis C screening strategies in hemodialysis patients. Am J Kidney Dis 38:91-97 (Pubitemid 32611764)
86. Saab S, Martin P, Brezina M, Gitnick G, Yee HF (2001b) Serum alanine aminotransferase in hepatitis C screening of patients on hemodialysis. Am J Kidney Dis 37:308-315 (Pubitemid 32116022)
87. Saboor B, Boroomand P, Mehrabi Y, Ghanbari M, Zarrinfam H (2003) Prevalence and risk factors of hepatitis C infection in hemodialysis patients (Kermanshah, 1999-2000) (in Persian). Behbood 7:60-66
88. Said RA, Hamzeh YY, Mehyar NS, Rababah MS (1995) Hepatitis C virus infection in hemodialysis patients in Jordan. Saudi J Kidney Dis Transplant 6:140-143
89. Salama G, Rostaing L, Sandres K, Izopet J (2000) Hepatitis C virus infection in French hemodialysis units: a multicenter study. J Med Virol 61:44-51 (Pubitemid 30191224)
90. Samimi-Rad K, Hosseini M, Shahbaz B (2008) Hepatitis C virus infection and HCV genotypes of hemodialysis patients. Iranian J Publ Health 37:146-152
91. Saxena AK, Panhotra BR, Naguib M, Aboras MN, Sundaram DS, Venkateshappa CK, Khan WU (2001) Prevalence of hepatitis C antibodies among hemodialysis patients in Al-hasa region of Saudi Arabia. Saudi J Kidney Dis Transplant 12:562-565 (Pubitemid 33374555)
92. Saxena AK, Panhotra BR, Sundaram DS et al (2003) Impact of dedicated space, dialysis equipment, and nursing staff on the transmission of hepatitis C virus in a hemodialysis unite of the Middle East. Am J Infect Control 31:26-33 (Pubitemid 36216572)
93. Sekkat S, Kamal N, Benali B et al (2008) Prevalence of anti-HCV antibodies and seroconversion incidence in five haemodialysis units in Morocco. Néphrol Thér 4:105-110 (Pubitemid 351508502)
94. Seyrafian S, Mobasherizadeh S, Javadi A, Akhzari M, Esfandiari J (2006) Comparison and prevalence of hepatitis B and C infection and hepatitis B vaccination in hemodialysis patients and staffs in 13 hemodialysis centers in Isfahan (Iran). Nephrol Dial Transplant 21 (Suppl 4):484
95. Shaheen FA, Huraib SO, al-Rashed R et al (1995) Prevalence of hepatitis C antibodies among hemodialysis patients in the Western province of Saudi Arabia. Saudi J Kidney Dis Transplant 6:136-139
96. Shamshirsaz AA, Kamgar M, Bekheirnia MR et al (2004) The role of hemodialysis machines dedication in reducing Hepatitis C transmission in the dialysis setting in Iran: a multicenter prospective interventional study. BMC Nephrol 5:13
97. Somi MH, Ardalan MR, Sokhanvar H, Pouri AA (2007) Hepatitis C virus infection in dialysis centers of Tabriz, Iran: a multicenter study. Iran J Clin Infect Dis 2:23-26
98. Soni PN, Tait DR et al (1993) Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus. J Med Virol 40:65-68 (Pubitemid 23142157)
99. Sorkhi H, Roushan MR, Al Hashemi GH, Dooki MR, Bai S (2008) Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection. East Mediterr Health J 14:798-803
100. Souqiyyeh MZ, Shaheen FA, Huraib SO, Al-Khader AA (1995) The annual incidence of seroconversion of antibodies to the hepatitis C virus in the hemodialysis population in Saudi Arabia. Saudi J Kidney Dis Transplant 6:167-173
101. Soyannwo MA, Khan N, Kommajosyula S et al (1996) Hepatitis C antibodies in haemodialysis and pattern of end-stage renal failure in Gassim, Saudi Arabia. Afr J Med Med Sci 25:13-22
102. Suliman SM, Fessaha S, El Sadig M, El-Hadi MB, Lambert S, Fields H, Ghalib HW (1995) Prevalence of hepatitis C virus infection in hemodialysis patients in Sudan. Saudi J Kidney Dis Transplant 6:154-156
103. Taziki O, Espahbodi F (2008) Prevalence of hepatitis C virus infection in hemodialysis patients. Saudi J Kidney Dis Transplant 19:475-478
104. Toosi MN, Larti F, Seifei S, Abdollahi A (2008) Prevalence of viral hepatitis in hemodialysis patients in Teheran, Iran. J Gastrointestin Liver Dis 17:233-234 (Pubitemid 351930776)
105. Tu AW, Buxton JA et al (2009) Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia: follow-up after a possible breach in hemodialysis machines. Can J Infect Dis Med Microbiol 20: e19-e23
106. Yang CS, Chang HH, Chou CC, Peng SJ (2003) Isolation effectively prevents the transmission of hepatitis C virus in the hemodialysis unit. J Formos Med Assoc 102:79-85
107. Zampieron A, Jayasekera H et al (2006) Sero-conversion of HCV negative patients: a European study on the epidemiology and management of HCV haemodialysis patients. EDTNA ERCA J 32:45-50